Literature DB >> 15906166

Experimental and computational studies of epithelial transport of mefenamic acid ester prodrugs.

Kamonthip Wiwattanawongsa1, Vimon Tantishaiyakul, Luelak Lomlim, Yon Rojanasakul, Sirirat Pinsuwan, Sanae Keawnopparat.   

Abstract

PURPOSE: A series of ester derivatives of mefenamic acid were synthesized with the aim of suppressing local gastrointestinal toxicity of mefenamic acid. A computational method was used to assist the design of the prodrug and to gain insights into the structure relationship of these compounds as P-glycoprotein (P-gp) substrates. The prodrugs were studied for their enzymatic stability, bidirectional permeability across Caco-2 monolayer, and their potential as transporter modulators
METHODS: Bidirectional transport studies were performed using Caco-2 cells. Compounds exhibiting an efflux ratio of > or =2 were further examined for their potential interaction with P-gp and multidrug resistance-associated protein (MRP) using verapamil and indomethacin. Calcein efflux inhibition studies were conducted to investigate the efflux mechanism of these compounds. Geometry optimization of the esters was performed, and the spatial separation of two electron donor groups of each prodrug was measured.
RESULTS: Morpholinoethyl ester (3) and pyrrolidinoethyl ester (4) of mefenamic acid showed evidence of efflux mechanism. Inhibition by verapamil had a pronounced effect on the transport of 3 and 4. Indomethacin, however, completely inhibited the apical efflux of 3 but enhanced the efflux ratio of 4. Both compounds increased the ratio of cellular calcein accumulation by 3- to 5-fold over control. Consistent with the experimental data, the computational results suggest the involvement of P-gp or its interaction in 3 and 4 transport.
CONCLUSIONS: Apical efflux of 3 is associated with P-gp and MRP, but the efflux of 4 involves P-gp and/or MRP. The computational approach used in this study provided the basis for P-gp substrates of compounds 3 and 4 from their electron donor subunits spatial separation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906166     DOI: 10.1007/s11095-005-2587-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Detection of MRP functional activity: calcein AM but not BCECF AM as a Multidrug Resistance-related Protein (MRP1) substrate.

Authors:  D P Olson; B J Taylor; S P Ivy
Journal:  Cytometry       Date:  2001-04-15

2.  Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.

Authors:  M Essodaigui; H J Broxterman; A Garnier-Suillerot
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

Review 3.  Antiinflammatory drugs and gastric mucosal damage.

Authors:  E L Semble; W C Wu
Journal:  Semin Arthritis Rheum       Date:  1987-05       Impact factor: 5.532

4.  P-glycoprotein-mediated transcellular transport of MDR-reversing agents.

Authors:  T Saeki; K Ueda; Y Tanigawara; R Hori; T Komano
Journal:  FEBS Lett       Date:  1993-06-07       Impact factor: 4.124

5.  Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.

Authors:  I Tamai; A R Safa
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

Review 6.  Progress in understanding the structure-activity relationships of P-glycoprotein.

Authors:  Terry R Stouch; Olafur Gudmundsson
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

7.  A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

Authors:  Julie E Penzotti; Michelle L Lamb; Erik Evensen; Peter D J Grootenhuis
Journal:  J Med Chem       Date:  2002-04-25       Impact factor: 7.446

8.  Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine939/941.

Authors:  S Kajiji; J A Dreslin; K Grizzuti; P Gros
Journal:  Biochemistry       Date:  1994-05-03       Impact factor: 3.162

9.  Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.

Authors:  O Legrand; G Simonin; J Y Perrot; R Zittoun; J P Marie
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

10.  Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.

Authors:  V K Tammara; M M Narurkar; A M Crider; M A Khan
Journal:  J Pharm Sci       Date:  1994-05       Impact factor: 3.534

View more
  2 in total

Review 1.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

Review 2.  Prodrugs of NSAIDs: A Review.

Authors:  Kamal Shah; Jeetendra K Gupta; Nagendra S Chauhan; Neeraj Upmanyu; Sushant K Shrivastava; Pradeep Mishra
Journal:  Open Med Chem J       Date:  2017-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.